Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume. Robyn Williams: Animal traps can produce incredible results, as they've shown in Los Angeles with ...
Spectrum announced that the FDA has approved the removal of the pre-treatment biodistribution evaluation requirement using Indium-111 Zevalin (radionuclide [B-lymphocyte-restricted differentiation ...
Treatment of Patients With Previously Untreated Follicular Non-Hodgkin’s Lymphoma (NHL), Who Achieve a Partial or Complete Response to First-Line Chemotherapy Treatment of Patients with Relapsed or ...
Definiens, the Enterprise Image Intelligence™ company, has signed a co-marketing agreement with Bioscan, Inc., a developer of advanced imaging instrumentation for radiolabeled compounds. Under the ...
BERLIN--(BUSINESS WIRE)--Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), specialists in radioactive pharmaceuticals and their production technology, has entered into an agreement ...
Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume. In a wild corner of north-east Victoria, more than 80 researchers have just spent two weeks counting ...
November 21, 2011 — The requirement that a bioscan be used to predetermine the distribution of ibritumomab tiuxetan (Zevalin, Spectrum Pharmaceuticals) has been removed, which will simplify treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results